235 related articles for article (PubMed ID: 32280711)
1. N
Zhang J; Chen Y; Liu C; Li L; Li P
J Diabetes Res; 2020; 2020():1080152. PubMed ID: 32280711
[TBL] [Abstract][Full Text] [Related]
2. N1‑methylnicotinamide ameliorates insulin resistance in skeletal muscle of type 2 diabetic mice by activating the SIRT1/PGC‑1α signaling pathway.
Chen Y; Zhang J; Li P; Liu C; Li L
Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33576435
[TBL] [Abstract][Full Text] [Related]
3. Gegen Qinlian Decoction Ameliorates Hepatic Insulin Resistance by Silent Information Regulator1 (SIRT1)-Dependent Deacetylation of Forkhead Box O1 (FOXO1).
Sui M; Chen G; Mao X; Wei X; Chen Y; Liu C; Fan Y
Med Sci Monit; 2019 Nov; 25():8544-8553. PubMed ID: 31719515
[TBL] [Abstract][Full Text] [Related]
4. Sodium meta-arsenite ameliorates hyperglycemia in obese diabetic db/db mice by inhibition of hepatic gluconeogenesis.
Lee YS; Lee EK; Oh HH; Choi CS; Kim S; Jun HS
J Diabetes Res; 2014; 2014():961732. PubMed ID: 25610880
[TBL] [Abstract][Full Text] [Related]
5. Yunpi Heluo decoction attenuates insulin resistance by regulating SIRT1-FoxO1 autophagy pathway in skeletal muscle of Zucker diabetic fatty rats.
Mao ZJ; Xia WS; Chai F
J Ethnopharmacol; 2021 Apr; 270():113828. PubMed ID: 33476712
[TBL] [Abstract][Full Text] [Related]
6. Leucine supplementation increases SIRT1 expression and prevents mitochondrial dysfunction and metabolic disorders in high-fat diet-induced obese mice.
Li H; Xu M; Lee J; He C; Xie Z
Am J Physiol Endocrinol Metab; 2012 Nov; 303(10):E1234-44. PubMed ID: 22967499
[TBL] [Abstract][Full Text] [Related]
7. Acute exercise reduces hepatic glucose production through inhibition of the Foxo1/HNF-4alpha pathway in insulin resistant mice.
De Souza CT; Frederico MJ; da Luz G; Cintra DE; Ropelle ER; Pauli JR; Velloso LA
J Physiol; 2010 Jun; 588(Pt 12):2239-53. PubMed ID: 20421289
[TBL] [Abstract][Full Text] [Related]
8. SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats.
Erion DM; Yonemitsu S; Nie Y; Nagai Y; Gillum MP; Hsiao JJ; Iwasaki T; Stark R; Weismann D; Yu XX; Murray SF; Bhanot S; Monia BP; Horvath TL; Gao Q; Samuel VT; Shulman GI
Proc Natl Acad Sci U S A; 2009 Jul; 106(27):11288-93. PubMed ID: 19549853
[TBL] [Abstract][Full Text] [Related]
9. MiR-542-5p Inhibits Hyperglycemia and Hyperlipoidemia by Targeting FOXO1 in the Liver.
Tian F; Ying HM; Wang YY; Cheng BN; Chen J
Yonsei Med J; 2020 Sep; 61(9):780-788. PubMed ID: 32882762
[TBL] [Abstract][Full Text] [Related]
10. A bioinformatics and transcriptomics based investigation reveals an inhibitory role of Huanglian-Renshen-Decoction on hepatic glucose production of T2DM mice via PI3K/Akt/FoxO1 signaling pathway.
Wu F; Shao Q; Xia Q; Hu M; Zhao Y; Wang D; Fang K; Xu L; Zou X; Chen Z; Chen G; Lu F
Phytomedicine; 2021 Mar; 83():153487. PubMed ID: 33636476
[TBL] [Abstract][Full Text] [Related]
11. SIRT1 mediates the role of RNA-binding protein QKI 5 in the synthesis of triglycerides in non-alcoholic fatty liver disease mice via the PPARα/FoxO1 signaling pathway.
Zhang W; Sun Y; Liu W; Dong J; Chen J
Int J Mol Med; 2019 Mar; 43(3):1271-1280. PubMed ID: 30664220
[TBL] [Abstract][Full Text] [Related]
12. Hepatic Sirt1 deficiency in mice impairs mTorc2/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance.
Wang RH; Kim HS; Xiao C; Xu X; Gavrilova O; Deng CX
J Clin Invest; 2011 Nov; 121(11):4477-90. PubMed ID: 21965330
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin F
Wang Y; Yan S; Xiao B; Zuo S; Zhang Q; Chen G; Yu Y; Chen D; Liu Q; Liu Y; Shen Y; Yu Y
Diabetes; 2018 Sep; 67(9):1748-1760. PubMed ID: 29773555
[TBL] [Abstract][Full Text] [Related]
14. Spexin alleviates insulin resistance and inhibits hepatic gluconeogenesis via the FoxO1/PGC-1α pathway in high-fat-diet-induced rats and insulin resistant cells.
Gu L; Ding X; Wang Y; Gu M; Zhang J; Yan S; Li N; Song Z; Yin J; Lu L; Peng Y
Int J Biol Sci; 2019; 15(13):2815-2829. PubMed ID: 31853220
[No Abstract] [Full Text] [Related]
15. Reciprocal Regulation of Hepatic TGF-β1 and Foxo1 Controls Gluconeogenesis and Energy Expenditure.
Pan Q; Ai W; Chen Y; Kim DM; Shen Z; Yang W; Jiang W; Sun Y; Safe S; Guo S
Diabetes; 2023 Sep; 72(9):1193-1206. PubMed ID: 37343276
[TBL] [Abstract][Full Text] [Related]
16. Estrogen Improves Insulin Sensitivity and Suppresses Gluconeogenesis via the Transcription Factor Foxo1.
Yan H; Yang W; Zhou F; Li X; Pan Q; Shen Z; Han G; Newell-Fugate A; Tian Y; Majeti R; Liu W; Xu Y; Wu C; Allred K; Allred C; Sun Y; Guo S
Diabetes; 2019 Feb; 68(2):291-304. PubMed ID: 30487265
[TBL] [Abstract][Full Text] [Related]
17. Feedback regulation of hepatic gluconeogenesis through modulation of SHP/Nr0b2 gene expression by Sirt1 and FoxO1.
Wei D; Tao R; Zhang Y; White MF; Dong XC
Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E312-20. PubMed ID: 21081708
[TBL] [Abstract][Full Text] [Related]
18. Elucidation of the anti-β-cell dedifferentiation mechanism of a modified Da Chaihu Decoction by an integrative approach of network pharmacology and experimental verification.
Chen H; Guo J; Cai Y; Zhang C; Wei F; Sun H; Cheng C; Liu W; He Z
J Ethnopharmacol; 2024 Mar; 321():117481. PubMed ID: 38007164
[TBL] [Abstract][Full Text] [Related]
19. Silymarin ameliorates the disordered glucose metabolism of mice with diet-induced obesity by activating the hepatic SIRT1 pathway.
Feng B; Huang B; Jing Y; Shen S; Feng W; Wang W; Meng R; Zhu D
Cell Signal; 2021 Aug; 84():110023. PubMed ID: 33901577
[TBL] [Abstract][Full Text] [Related]
20. N1-methylnicotinamide impairs gestational glucose tolerance in mice.
Wei X; Tan Y; Huang J; Dong X; Feng W; Liu T; Yang Z; Yang G; Luo X
J Mol Endocrinol; 2024 Feb; 72(2):. PubMed ID: 38029302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
